What is a stock summary page? Click here for an overview.
Business Description
Adlai Nortye Ltd
NAICS : 541714
SIC : 2834
ISIN : US00704R1095
Share Class Description:
ANL: ADRDescription
Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The company has a robust pipeline of drug candidates which includes buparlisib (AN2025), palupiprant (AN0025), and AN4005 in the clinical stage, and AN8025, AN9025, and AN1025 in the preclinical stage.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 2.48 | |||||
| Equity-to-Asset | 0.5 | |||||
| Debt-to-Equity | 0.74 | |||||
| Debt-to-EBITDA | -0.51 | |||||
| Piotroski F-Score | N/A/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Future 3-5Y EPS without NRI Growth Rate Estimate | 44.75 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 36.64 | |||||
| 9-Day RSI | 44.64 | |||||
| 14-Day RSI | 48.15 | |||||
| 3-1 Month Momentum % | 3.24 | |||||
| 6-1 Month Momentum % | 3.72 | |||||
| 12-1 Month Momentum % | -75.49 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.85 | |||||
| Quick Ratio | 1.85 | |||||
| Cash Ratio | 1.8 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -27.27 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| FCF Margin % | -368.16 | |||||
| ROA % | -77.29 | |||||
| ROIC % | -20.56 | |||||
| ROC (Joel Greenblatt) % | -2073.42 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 6.81 | |||||
| PB Ratio | 1.61 | |||||
| Price-to-Tangible-Book | 1.61 | |||||
| EV-to-EBIT | 0.15 | |||||
| EV-to-Forward-EBIT | -0.34 | |||||
| EV-to-EBITDA | 0.16 | |||||
| EV-to-Forward-EBITDA | -0.34 | |||||
| EV-to-Revenue | -2.41 | |||||
| EV-to-FCF | 0.66 | |||||
| Price-to-Net-Current-Asset-Value | 1.86 | |||||
| Price-to-Net-Cash | 1.97 | |||||
| Earnings Yield (Greenblatt) % | 666.67 | |||||
| FCF Yield % | -21.41 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:ANL
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Adlai Nortye Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 5 | ||
| EPS (TTM) ($) | -2.12 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 110.09 | ||
| 14-Day RSI | 48.15 | ||
| 14-Day ATR ($) | 0.157719 | ||
| 20-Day SMA ($) | 2.260455 | ||
| 12-1 Month Momentum % | -75.49 | ||
| 52-Week Range ($) | 1.85 - 17.48 | ||
| Shares Outstanding (Mil) | 36.9 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Adlai Nortye Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Adlai Nortye Ltd Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Adlai Nortye Ltd Frequently Asked Questions
What is Adlai Nortye Ltd(ANL)'s stock price today?
The current price of ANL is $2.33. The 52 week high of ANL is $17.48 and 52 week low is $1.85.
When is next earnings date of Adlai Nortye Ltd(ANL)?
The next earnings date of Adlai Nortye Ltd(ANL) is 2025-08-08 Est..
Does Adlai Nortye Ltd(ANL) pay dividends? If so, how much?
Adlai Nortye Ltd(ANL) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers